Nevro Corp reports results for the quarter ended in December - Earnings Summary

Nevro

23/02/2024 03:15

* Nevro Corp  NVRO.N  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -54
cents.  The mean expectation of sixteen analysts for the quarter
was for a loss of 49 cents per share. Wall Street expected
results to range from -66 cents to -30 cents per share.
    * Revenue rose 2% to $116.18 million from a year ago;
analysts
expected $112.48 million. 
    * Nevro Corp's reported EPS for the quarter was a loss of 25
cents​.
    * The company reported a quarterly loss of $8.98 million.
    * Nevro Corp shares had fallen by 22.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 13
"hold" and 4 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Nevro Corp is
$18.00 
This summary was machine generated from LSEG data February 23 at
03:14 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.49          -0.25          Beat
 Sep. 30 2023      -0.77          -0.65          Beat
 Jun. 30 2023      -0.69          -0.69          Met
 Mar. 31 2023      -1.04          -0.98          Beat